Cholera: A Crisis of Deprivation, Not Science
In 2024, cholera has claimed over 6,800 lives in 32 countries, surpassing last year's death toll by 50%. The most severe outbreaks are in Africa, where conflict is fueling the spread and hindering control efforts. Despite being considered an ancient disease, with the last outbreak in Britain occurring in 1866, cholera persists due to inadequate leadership responses.
The World Health Organization (WHO) has launched a continental emergency response plan for cholera, which aims to improve detection, prevention, and treatment of the disease. The Global Task Force on Cholera Control has also been instrumental in responding to outbreaks through access to essential supplies and setting global priorities for sustainable control.
Cholera is caused by contaminated food or water, highlighting the importance of safe drinking water and sanitation. However, these basic necessities are often lacking in communities plagued by poverty, conflict, displacement, and climate-related disasters. Effective vaccines can prevent cholera, but investment in vaccine development lags due to limited market opportunities.
The WHO has a global cholera vaccine stockpile that has distributed over 255 million doses of vaccine since its establishment in 2013. However, production cannot keep up with demand, and the stockpile is regularly below the recommended threshold. The International Coordinating Group on Vaccine Provision has suspended standard vaccination regimens to stretch supplies further.
Zambia has recently signed a memorandum of understanding with China's Jijia Medical Technology Company to establish a cholera vaccine-production facility in Lusaka. While expanding vaccine production is essential, governments must also prioritize investments in safe drinking water and sanitation to prevent the spread of cholera.
The root cause of the crisis lies not in scientific or medical limitations but in inadequate political responses to poverty, inequality, conflict, and displacement. As Tedros Adhanom Ghebreyesus, Director-General of the WHO, notes, "Cholera is not a disease that cannot be stopped; it can be stopped." The challenge lies in mobilizing governments to invest in preventive measures, ensuring equitable access to essential supplies, and sustaining control efforts.
As Hakainde Hichilema, President of Zambia and Control Champion for the Global Task Force on Cholera Control, emphasizes, "Leadership failures are exacerbating the crisis. We need urgent action from governments, donors, and international partners to tackle cholera head-on." It is time to consign cholera to history by addressing its underlying causes through concerted efforts in policy, finance, and infrastructure development.
In 2024, cholera has claimed over 6,800 lives in 32 countries, surpassing last year's death toll by 50%. The most severe outbreaks are in Africa, where conflict is fueling the spread and hindering control efforts. Despite being considered an ancient disease, with the last outbreak in Britain occurring in 1866, cholera persists due to inadequate leadership responses.
The World Health Organization (WHO) has launched a continental emergency response plan for cholera, which aims to improve detection, prevention, and treatment of the disease. The Global Task Force on Cholera Control has also been instrumental in responding to outbreaks through access to essential supplies and setting global priorities for sustainable control.
Cholera is caused by contaminated food or water, highlighting the importance of safe drinking water and sanitation. However, these basic necessities are often lacking in communities plagued by poverty, conflict, displacement, and climate-related disasters. Effective vaccines can prevent cholera, but investment in vaccine development lags due to limited market opportunities.
The WHO has a global cholera vaccine stockpile that has distributed over 255 million doses of vaccine since its establishment in 2013. However, production cannot keep up with demand, and the stockpile is regularly below the recommended threshold. The International Coordinating Group on Vaccine Provision has suspended standard vaccination regimens to stretch supplies further.
Zambia has recently signed a memorandum of understanding with China's Jijia Medical Technology Company to establish a cholera vaccine-production facility in Lusaka. While expanding vaccine production is essential, governments must also prioritize investments in safe drinking water and sanitation to prevent the spread of cholera.
The root cause of the crisis lies not in scientific or medical limitations but in inadequate political responses to poverty, inequality, conflict, and displacement. As Tedros Adhanom Ghebreyesus, Director-General of the WHO, notes, "Cholera is not a disease that cannot be stopped; it can be stopped." The challenge lies in mobilizing governments to invest in preventive measures, ensuring equitable access to essential supplies, and sustaining control efforts.
As Hakainde Hichilema, President of Zambia and Control Champion for the Global Task Force on Cholera Control, emphasizes, "Leadership failures are exacerbating the crisis. We need urgent action from governments, donors, and international partners to tackle cholera head-on." It is time to consign cholera to history by addressing its underlying causes through concerted efforts in policy, finance, and infrastructure development.